EuroHealth%reg; EuroHealth%reg; EuroHealth%reg; EuroHealth%reg; EuroHealth%reg;
ALKYROL® Referenzen   [Drucken]

Brohult, A; (1963) “Alkylglycerols and Their Use in Radiation Treatment”.Acta Radiol, Suppl 223.

Brohult, A, et al; (1978) “Regression of Tumor Growth After Administration of Alkylglycerols”. Acta Obstet Gynecol Scand 57:1,79

Fredin, B; (1987) “Studies on the Mercury Release form Dental Amalgam Fillings”. Department of Physiological Chemistry IV, University of Lund, Sweden.

Pugliese, PT, Jordan K, Cederberg H, Brohult J “Some Biological Actions of Alkyglycerols from Shark Liver Oil” The Journal of Alternative and Complementary Medicine Vol. 4, No. 1, 1998, pp87-99

Pugliese, PT, Heinerman, J; (1999) Devour Disease with Shark Liver Oil, Ed. IMPAKT Communications. Green Bay, WI

Wang, HM, Rajagopa, LS, Reynolds, S, Jordan, K, Cederberg H. and Chakrabarty, S; (1998) “Differentiation-inducing effects of 1-0 (2 methoxy) hexadecyl glycerol in human colon cancer cells”. Proceeds of the American Assoc. for Cancer Research, Vol. 39.

Yamamoto, N, St. Clair, DA, Homma, S, Nywenya, B; (1998) “Activation of Macrophages by Alkylglycerols, Inflammation Products of Cancerous Tissues”. Cancer Research, 48:6044-9

Reynolds S., Cederberg H., Chakrabarty S. (2001) “Inhibitory effect of 1-0 (2 methoxy) hexadecyl glycerol and phenylbutyrate on the malignant properties of human prostate cancer cells” Journal of Clinical and Experimental Metastasis
© 2019 EuroHealth®